Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07662135
PHASE3

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin

Sponsor: AstraZeneca

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron, compared with placebo in adults with type 2 diabetes mellitus (T2DM) and impaired renal function, who are or will be on a background of sodium-glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin 10 mg as per guideline directed medical therapy (GDMT) for chronic kidney disease (CKD). Additionally, participants are on other glucose-lowering medication(s).

Official title: A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin (Eluminate-4)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

900

Start Date

2026-07-06

Completion Date

2028-07-13

Last Updated

2026-09-02

Healthy Volunteers

No

Interventions

DRUG

Elecoglipron

Elecoglipron is administered orally once daily.

DRUG

Placebo

Placebo is administered orally once daily.

Locations (186)

Research Site

Sun City, Arizona, United States

Research Site

Surprise, Arizona, United States

Research Site

Concord, California, United States

Research Site

Sacramento, California, United States

Research Site

Victorville, California, United States

Research Site

Fleming Island, Florida, United States

Research Site

Lauderdale Lakes, Florida, United States

Research Site

Leesburg, Florida, United States

Research Site

Miami Lakes, Florida, United States

Research Site

Ocoee, Florida, United States

Research Site

Orlando, Florida, United States

Research Site

Chicago, Illinois, United States

Research Site

Braintree, Massachusetts, United States

Research Site

New Bedford, Massachusetts, United States

Research Site

Worcester, Massachusetts, United States

Research Site

Saint Joseph, Michigan, United States

Research Site

Saint Paul, Minnesota, United States

Research Site

Kansas City, Missouri, United States

Research Site

Omaha, Nebraska, United States

Research Site

Las Vegas, Nevada, United States

Research Site

Albuquerque, New Mexico, United States

Research Site

The Bronx, New York, United States

Research Site

Kinston, North Carolina, United States

Research Site

Raleigh, North Carolina, United States

Research Site

Winston-Salem, North Carolina, United States

Research Site

Cincinnati, Ohio, United States

Research Site

East Providence, Rhode Island, United States

Research Site

Gaffney, South Carolina, United States

Research Site

Greenville, South Carolina, United States

Research Site

San Antonio, Texas, United States

Research Site

San Antonio, Texas, United States

Research Site

Ogden, Utah, United States

Research Site

Arlington, Virginia, United States

Research Site

Dupnitsa, Bulgaria

Research Site

Haskovo, Bulgaria

Research Site

Kyustendil, Bulgaria

Research Site

Pleven, Bulgaria

Research Site

Plovdiv, Bulgaria

Research Site

Rousse, Bulgaria

Research Site

Stara Zagora, Bulgaria

Research Site

Varna, Bulgaria

Research Site

Varna, Bulgaria

Research Site

Binzhou, China

Research Site

Changsha, China

Research Site

Chengdu, China

Research Site

Hangzhou, China

Research Site

Jinan, China

Research Site

Liaocheng, China

Research Site

Liuzhou, China

Research Site

Luoyang, China

Research Site

Nanjing, China

Research Site

Nanyang, China

Research Site

Suining Shi, China

Research Site

Yibin, China

Research Site

Yichang, China

Research Site

Zhengzhou, China

Research Site

Zhengzhou, China

Research Site

Aarhus N, Denmark

Research Site

Gistrup, Denmark

Research Site

Herlev, Denmark

Research Site

Hillerød, Denmark

Research Site

Holbæk, Denmark

Research Site

Hvidovre, Denmark

Research Site

Bad Oeynhausen, Germany

Research Site

Berlin, Germany

Research Site

Brandenburg an der Havel, Germany

Research Site

Chemnitz, Germany

Research Site

Duisburg, Germany

Research Site

Duisburg, Germany

Research Site

Erlangen, Germany

Research Site

Frankfurt, Germany

Research Site

Hamburg, Germany

Research Site

Heilbronn, Germany

Research Site

Hohenmölsen, Germany

Research Site

Ludwigshafen, Germany

Research Site

Münster, Germany

Research Site

Nittendorf, Germany

Research Site

Obertshausen, Germany

Research Site

Pirna, Germany

Research Site

Sankt Ingbert, Germany

Research Site

Stuttgart, Germany

Research Site

Aligarh, India

Research Site

Belagavi, India

Research Site

Belgavi, India

Research Site

Calicut, India

Research Site

Chennai, India

Research Site

Chennai, India

Research Site

Coimbatore, India

Research Site

Delhi, India

Research Site

Guntur, India

Research Site

Kolkata, India

Research Site

Lucknow, India

Research Site

Nagpur, India

Research Site

Pune, India

Research Site

Chigasaki-shi, Japan

Research Site

Chikushino-shi, Japan

Research Site

Gifu, Japan

Research Site

Kagoshima, Japan

Research Site

Kitakyushu, Japan

Research Site

Kumamoto, Japan

And 86 more locations on ClinicalTrials.gov